JPS61291535A - Optical resolution of 1,1'-bi-2-naphthol derivative - Google Patents

Optical resolution of 1,1'-bi-2-naphthol derivative

Info

Publication number
JPS61291535A
JPS61291535A JP13265285A JP13265285A JPS61291535A JP S61291535 A JPS61291535 A JP S61291535A JP 13265285 A JP13265285 A JP 13265285A JP 13265285 A JP13265285 A JP 13265285A JP S61291535 A JPS61291535 A JP S61291535A
Authority
JP
Japan
Prior art keywords
optically active
compound
mixture
racemic
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP13265285A
Other languages
Japanese (ja)
Other versions
JPH0580461B2 (en
Inventor
Kazutaka Arai
和孝 新井
Yoshio Obara
義夫 小原
Hiroo Matsumoto
浩郎 松本
Shuji Tsuchiya
土屋 脩二
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissan Chemical Corp
Original Assignee
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Corp filed Critical Nissan Chemical Corp
Priority to JP13265285A priority Critical patent/JPS61291535A/en
Publication of JPS61291535A publication Critical patent/JPS61291535A/en
Publication of JPH0580461B2 publication Critical patent/JPH0580461B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PURPOSE:To carry out the crystallization resolution of the titled compound, by using racemic 1,1'-bi-2-naphthol derivative or a mixture containing one of the optically active isomer in excess as a raw material, dissolving the material in a solvent, cooling the solution to a supersaturated state and adding the crystal of an optically active isomer to the solution. CONSTITUTION:Racemic compound of formula (R<1> and R<2> are alkyl) or a mixture of the compound containing one of the optically active isomer in excess is dissolved in a solvent (e.g. hexane, benzene, etc.), cooled to supersaturated state, and added with the crystal of an optically active compound as a seed crystal to the solution in an amount of 1-20wt% based on the racemic compound or the mixture to effect the crystallizing resolution of the compound. EFFECT:The process can be carried out extremely economically without necessitating expensive or hardly available optical resolution agent.

Description

【発明の詳細な説明】 本発明は式(1) (式中、 R1およびR2はアルキル基を示す。)で表
わされる1、1′−ビー2−ナフトール誘導体の光学活
性体の製法に関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing an optically active 1,1'-bi-2-naphthol derivative represented by formula (1) (wherein R1 and R2 represent an alkyl group). be.

さらに、前記の化合物(1)の光学活性体は立体保持的
に脱アルキル化することにより2式(2)で表わされる
1、1′−ビー2−ナフトールの光学活性体く導びくこ
とかできるので2本発明の方法は光学活性な1,1′−
ビー2−す7トール裂造の中間体の製造に有用である。
Furthermore, the optically active form of the above compound (1) can be converted into the optically active form of 1,1'-bi-2-naphthol represented by the formula (2) by steric dealkylation. Therefore, the method of the present invention is suitable for optically active 1,1'-
It is useful in the production of intermediates for B2-S7 toll construction.

また1式(2)で表わされる化合物は光学活性な配位子
あるいは相間移動触媒等の用途がある。
Furthermore, the compound represented by Formula 1 (2) has uses such as optically active ligands and phase transfer catalysts.

光学活性な式(2)で表わされる1、1′−ビー2−ナ
フトールは、その軸性キラリティーに特色がある光学活
性化合物で、ケトン不斉還元の際の配位子、アミノ酸等
の光学分割能力を有する光学活性クラクンエーテルの原
料、あるいはそのまま非対称スルホキシド類の化学分割
剤等として有用な化合物である。
The optically active 1,1'-bi-2-naphthol represented by the formula (2) is an optically active compound characterized by its axial chirality, and is used as a ligand for asymmetric reduction of ketones, or as an optical compound for amino acids, etc. It is a compound useful as a raw material for optically active kracune ether having resolution ability, or as a chemical resolution agent for asymmetric sulfoxides as it is.

従来の技術 従来、光学活性な1,1′−ビー2−ナフトールを得る
方法としては#1t”−ビー2−す7トールの2セミ体
を光学分割する次の様な方法が知られている。
BACKGROUND ART Conventionally, as a method for obtaining optically active 1,1'-bi-2-naphthol, the following method of optically resolving two semiforms of #1t''-bi-2-naphthol has been known. .

(1)  リン酸エステルを経由して、シンコニジン塩
として光学分割後、リン酸エステルを切断する方法(T
e論樋bn TJBtt、、 1 q 71461 y
 )。
(1) A method in which the phosphoric ester is cleaved after optical resolution as cinchonidine salt via the phosphoric ester (T
e-ronhi bn TJBtt,, 1 q 71461 y
).

(2)  光学活性なメチル m−)リル スルホキシ
ドを分割剤とする方法(Tetrahairon Le
tt、、 f?84492?)。
(2) A method using optically active methyl m-)lyl sulfoxide as a resolving agent (Tetrahairon Le
tt,, f? 84492? ).

解決しようとする問題点 従来の技術は、共通の問題として1,1′−ビー2−ナ
フトールのラセミ体が水に対し難溶性であるにもかかわ
らず、難溶性の水の中でラセミ体を合成する必要があり
、ラセミ体合成が容易でないという問題がある。また、
上述の(1)の方法は比較的高価なシンコニジンを用い
ること、多工程を要することという問題があり、(2)
の方法はかなシ簡便な方法であるがメチル m−)リル
 スルホキシドの、しかも光学活性体という入手しにく
い分割剤を用いるという問題がある。
Problems to be Solved Conventional techniques have a common problem that the racemic form of 1,1'-bi-2-naphthol is sparingly soluble in water; There is a problem in that racemic synthesis is not easy. Also,
The above method (1) has the problems of using relatively expensive cinchonidine and requiring multiple steps, and (2)
Although this method is quite simple, it has the problem of using a difficult-to-obtain resolving agent, which is an optically active form of methyl m-)lyl sulfoxide.

問題点を解決するための手段 本発明者らは、1,1−ビー2−ナフトールのラセミ体
を経由しない、かつ高価なおよび/あるいは入手困難な
光学分割剤を用いない光学活性な1.1′−ビー2−ナ
フトールの製法を鋭意検討し。
Means for Solving the Problems The present inventors have developed optically active 1.1 that does not pass through the racemic form of 1,1-bi-2-naphthol and does not use an expensive and/or difficult-to-obtain optical resolving agent. '-B-2-naphthol production method was studied intensively.

(1)先ず1本発明者らが既に出願した製法(特許11
1360−15065)の方法で2−アルコキシナフタ
レンから難溶性の1,1′−ビー2−ナフトールを経る
ことなく直接、あるいは必要に応じて前記一般式(2)
で表わされる1、1′−と−2−す7トールの2セミ体
をアルキル化する方法等によって前記一般式(1)で表
わされる1、1′−ビー2−ナフトール誘導体を得;(
2)次にこの1.1′−ビー2−ナフトール誘導体を所
謂、優先晶出法で光学分割しそのまま利用するか;ある
いは(3)さらにこの1゜1′−ビー2−ナフトール誘
導体の光学活性体を立体保持的に脱アルキル化すること
によシ光学活性な1,1′−ビー2−す7トールを得る
という製法を完成した。
(1) First, the manufacturing method for which the present inventors have already applied (Patent No. 11)
1360-15065) directly from 2-alkoxynaphthalene without passing through the poorly soluble 1,1'-bi-2-naphthol, or as necessary, the general formula (2)
A 1,1'-bi-2-naphthol derivative represented by the general formula (1) is obtained by alkylating the 2 semiforms of 1,1'- and -2-7tol represented by; (
2) Next, optically resolve this 1.1'-bi-2-naphthol derivative by a so-called preferential crystallization method and use it as it is; or (3) further improve the optical activity of this 1.1'-bi-2-naphthol derivative. We have completed a process for obtaining optically active 1,1'-be-2-7-toll by dealkylating the body in a steric-retentive manner.

本発明の方法をさらに詳しく説明する。前記一般式(1
)により表わされる1、1′−と−2−ナフトール誘導
体の2セミ体あるいは、一方の光学活性体が他方の光学
活性体よりも過剰に存在する混合体の優先晶出に際し、
先ず混合体を有機溶媒に溶解させる。
The method of the present invention will be explained in more detail. The general formula (1
) or a mixture in which one optically active form is present in excess over the other optically active form,
First, the mixture is dissolved in an organic solvent.

使用される溶媒は、ラセミ体の溶解度の方が光学活性体
の溶解度よルも大きいものが好ましい。例工ば、ヘキサ
ン、ベンゼン、トルエンのような炭化水素類;エチルエ
ーテル、イングロビルエーテルのよウナエーテル類;ク
ロロホルム、ジクロロメタンのようなハロゲン化炭化水
素類;メタノール、エタノール、インプロパツール(工
PA)、t−ブタノールのようなアルコール類;アセト
ン、メチルエチルケトン、酢酸メチル、 DM80. 
DMIF のような非プロトン性極性溶媒類及びこれら
の混合溶媒を用いることができる。
The solvent used is preferably one in which the solubility of the racemate is greater than the solubility of the optically active substance. For example, hydrocarbons such as hexane, benzene, and toluene; ethers such as ethyl ether and inglovir ether; halogenated hydrocarbons such as chloroform and dichloromethane; methanol, ethanol, and impropanol. , alcohols such as t-butanol; acetone, methyl ethyl ketone, methyl acetate, DM80.
Aprotic polar solvents such as DMIF and mixtures thereof can be used.

次に冷却し過飽和とする。過飽和の程度は少ない方が得
られる結晶の光学純度が高くなるが。
Next, it is cooled to supersaturation. However, the smaller the degree of supersaturation, the higher the optical purity of the obtained crystal.

1回で得られる量が少なくなる。通常その温度でのラセ
ミ体の溶解度の10ないし100%を析出させる様に過
飽和とする。但し、一方の光学活性体が他方の光学活性
体よシも過剰に存在する混合物の場合は、この過剰分を
予め考慮しておく必要がある。
The amount you can get at one time will be smaller. Usually, supersaturation is achieved so that 10 to 100% of the solubility of the racemate at that temperature is precipitated. However, in the case of a mixture in which one optically active substance is present in excess of the other optically active substance, this excess must be taken into consideration in advance.

次に接種する。接種する光学活性体は、ラセミ体あるい
はほぼラセミ体に近い混合体を用いる場合は、!体、S
体のいずれでも良いが、一方の光学活性体が他方の光学
活性体よりも過剰に存在する場合は、過剰な側の光学活
性体が望ましい。
Next, inoculate. If the optically active substance to be inoculated is a racemate or a mixture close to a racemate, then! body, S
Any of the optically active forms may be used, but when one optically active form is present in excess compared to the other optically active form, the optically active form in the excess is desirable.

種晶の添加量1粒度には特に制限はないが。There are no particular restrictions on the amount and particle size of seed crystals added.

通常は、溶液中のラセミ体または部分分割された混合体
に対し1〜20重量%程度の結晶を砕いた粉末を用いる
のが適当である。
Usually, it is appropriate to use a powder obtained by crushing crystals in an amount of about 1 to 20% by weight based on the racemate or partially separated mixture in the solution.

晶析は、冷却による方法、溶媒を留去する方法、溶解度
が小さい溶媒を滴下する方法等が可能であシ、また回分
法の他、連続晶析装置の導入も可能である。晶出速度の
調整が重要であり。
The crystallization can be carried out by cooling, by distilling off the solvent, by dropping a solvent with low solubility, etc. In addition to the batch method, it is also possible to introduce a continuous crystallizer. Adjustment of crystallization rate is important.

晶出速度をゆっくシにすると析出する結晶の光学純度が
高くなる傾向がある。
When the crystallization rate is slowed down, the optical purity of the precipitated crystals tends to increase.

この様にして得られた前記の化合物(1)の光学活性体
を立体保持的に脱アルキル化し、1.1−と−2−す7
トールを得る方法としては、ハロゲン化水素および含水
有機カルボン酸での加熱による方法(たとえば、ヨウ化
水素酸−酢酸あるいは臭化水素酸−酢酸)、三臭化ホウ
素と低温で処理する方法〔たとえばJ、 Amer、 
Chew、soc、 。
The optically active form of the compound (1) thus obtained was dealkylated in a steric retention manner, and 1.1- and -2-7
Methods for obtaining toll include heating with hydrogen halide and a hydrous organic carboxylic acid (e.g., hydroiodic acid-acetic acid or hydrobromic acid-acetic acid), and treatment with boron tribromide at low temperature [e.g. J, Amer,
Chew, soc.

104.881(1982))等が挙げられる。104.881 (1982)).

発明の作用効果 高価なあるいは入手しにくい光学分割剤を必要とせず、
最初にどちらか一方の種晶を小量用意するだけで得られ
た結晶を次回の種晶としてめ、工業的に有利な方法であ
る。
Effects of the invention: No expensive or difficult-to-obtain optical resolving agents are required;
This method is industrially advantageous because it requires only a small amount of one of the seed crystals to be prepared first, and the resulting crystals are used as the next seed crystals.

また、原料に用いる式(すで表わされる1、1’−ビー
2−ナフトール誘導体は、従来法に於て用いられる式(
2)で表わされる1、1−ビー2−ナフトール誘導体よ
シ合成がはるかに容易である。
In addition, the 1,1'-bi-2-naphthol derivative represented by the formula (already expressed) used as a raw material is the formula (
The 1,1-bi-2-naphthol derivative represented by 2) is much easier to synthesize.

実施例 奏1μ 以下に実施例を示し、さらに詳しく説明する。なお2発
明はこれら実施例によって限定されるものではない。
Example 1μ An example will be shown below and will be explained in more detail. Note that the second invention is not limited to these Examples.

参考例1゜ 2−メトキシナフタレン1.58 fを塩化メチレン1
00−に溶解させ、−10〜−15Cの浴上で攪拌冷却
した。これに塩化第2鉄1261を少しずつ加え攪拌、
添加終了後さらに30分間攪拌した後、水50dを少し
ずつ加えた。水添加後充分攪拌し黒褐色の液の色が淡黄
色に変化した後、徐々に室温に戻した。分液し得た有機
層を濃縮し、さらに蒸留し1,1′−と−2−メトキシ
ナフタレンのラセミ体t1 atを無色油状物として得
九。このものはすぐに固化した。収率75チ。物性値は
以下の通りであった。
Reference example 1゜1.58 f of 2-methoxynaphthalene to 1 methylene chloride
00- and stirred and cooled on a -10 to -15C bath. Add ferric chloride 1261 little by little to this and stir.
After the addition was completed, the mixture was stirred for an additional 30 minutes, and then 50 d of water was added little by little. After adding water, the mixture was thoroughly stirred and the color of the dark brown liquid changed to pale yellow, after which the temperature was gradually returned to room temperature. The separated organic layer was concentrated and further distilled to obtain racemic t1at of 1,1'- and -2-methoxynaphthalene as a colorless oil. This stuff solidified quickly. Yield: 75 cm. The physical property values were as follows.

mp  199〜202.50(ベンゼン)NMR(C
DO12)δ174(s、 6H)、 7.15〜11
20(m、 12H)MS (m/e)314 (M+
、 100)、 268(10)なお、物性値は市販の
1,1′−ビー2−ナフトールをジメチルホルムアミド
中、ヨウ化メチルおよび水素化ナトリウムでメチル化し
て得た標品のそれらと一致した。
mp 199-202.50 (benzene) NMR (C
DO12) δ174(s, 6H), 7.15-11
20 (m, 12H) MS (m/e) 314 (M+
, 100), 268 (10) The physical properties were consistent with those of a standard product obtained by methylating commercially available 1,1'-bi-2-naphthol with methyl iodide and sodium hydride in dimethylformamide.

実施例1゜ 参考例tで得られた1、17−と−2−メトキシナフタ
レンのラセミ体201.511pをベンゼンLOfに溶
解させた後24Cに冷却し、粉末化した光学活性体6 
t 4 !n9((r)’; −44,0°(c=1、
0 、 CHCl5 )、 85.3 % e、e、)
を接種した。14時間かけて、ゆっ(J+2−ICから
9Cまこ攪拌しながら冷却し、濾過した。結晶部分は1
62.5IIgで〔a〕25−17.5°(5五9%a
e、)、テ液り 部分を濃縮すると97.511gで〔α〕0+λ3G(
4,5%e、e、)だった。1体、d体が5〜5II#
9増大したことになる。
Example 1゜The racemic body 201.511p of 1,17- and -2-methoxynaphthalene obtained in Reference Example t was dissolved in benzene LOf, cooled to 24C, and powdered optically active substance 6.
T4! n9((r)'; -44,0°(c=1,
0, CHCl5), 85.3% e,e,)
was inoculated. It was slowly cooled for 14 hours with stirring (from J+2-IC to 9C) and filtered.
62.5IIg [a] 25-17.5° (559%a
e,), when the liquid part is concentrated, it becomes 97.511g [α]0+λ3G(
It was 4.5% e, e,). 1 body, d body is 5~5II#
This means that the number has increased by 9.

実施例2 1.1′−ビー2−メトキシナフタレンのラセミ体51
5ダをクロロホルム12.Ofに溶解させた後20Cに
冷却し、粉末化した光学活性体24.6■(〔α式+5
1.1°(c=1.0. CHCLs )。
Example 2 1.1'-B-2-methoxynaphthalene racemate 51
5 Da to chloroform 12. Optically active substance 24.6■ ([α formula +5
1.1° (c=1.0.CHCLs).

99.0%e、e、 )を接種した。19〜21Cで1
時間攪拌し濾過した。結晶部分は1248119で[f
f]、 +1 &7°(32−4%e、e、)、  P
液部分を濃縮すると4241n9で〔α〕2:、  Z
 so(4,8%e、e、)だった。d体、1体が17
〜211n9増大したことになる。
99.0% e, e, ) was inoculated. 1 at 19-21C
Stir for an hour and filter. The crystal part is 1248119 [f
f], +1 &7° (32-4% e, e,), P
When the liquid part is concentrated, it becomes 4241n9 [α]2:, Z
so (4.8% e, e,). d body, one body is 17
~211n9 increased.

実施例五 11’−ビー2−メトキシナフタレンの2セミ体164
4In9とd体451ng((α)o+51.6°(c
=LD、 0FiC1,)、 no%e、e、)の混合
体をクロロホルム3&Ofに溶解させた後20Cに冷却
し、粉末化した光学活性体3L6Fng((α〕o+5
7.80,75.5%e、e、 )を接種した。20C
で1時間攪拌し濾過した。結晶部分は273F!Igで
(a)H+ 2 Noo(44,6%e、e、)であっ
た。4体が99ダ増大したことになる。
Example 5 11'-B-2-methoxynaphthalene 2-semiconductor 164
4In9 and d-isomer 451ng ((α)o+51.6°(c
A mixture of =LD, 0FiC1,), no%e, e,) was dissolved in chloroform 3&Of, cooled to 20C, and powdered optically active substance 3L6Fng ((α]o+5
7.80, 75.5% e, e, ) were inoculated. 20C
The mixture was stirred for 1 hour and filtered. The crystal part is 273F! For Ig, (a) H+ 2 Noo (44.6% e, e,). This means that 4 bodies have grown by 99 da.

このF液部分からクロロホルムを1.Of留去した後、
再溶解させ、20Cに冷却した。
From this F solution part, 1. After distilling off,
Redissolved and cooled to 20C.

粉末化した光学活性体390ダ(〔α〕甘せ44.0°
Powdered optically active substance 390 da ([α] Amase 44.0°
.

8a5%e、e、)を接種し、20Cで1時間攪拌し濾
過した。結晶部分は349ダで〔α)D−sin。
8a5%e, e,) was inoculated, stirred at 20C for 1 hour, and filtered. The crystal part is 349 da [α) D-sin.

(69,8%e、e、)で、1体が2101v増大した
ことになる。このものをクロロホルム4,3fで還流温
度まで加熱、溶解し、さらに20Cまでゆっくり冷却し
た後炉遇し、無色結晶185vを得た。(α:+: −
51,5°(9y、4%e、e、)。mp232〜23
4.5C(ベンゼン) NMR,MS  の値は実施例
tの2セミ体と同じであった。
(69.8% e, e,), which means that one body has increased by 2101v. This material was heated and dissolved in 4.3 f of chloroform to the reflux temperature, further cooled slowly to 20 C, and then heated in an oven to obtain 185 v of colorless crystals. (α:+:-
51,5° (9y, 4% e, e,). mp232-23
The 4.5C (benzene) NMR and MS values were the same as those of the 2 semiform of Example t.

参考例2 参考例1.の2−メトキシナフタレン1.58fの代り
に、2−エトキシナフタレン1.72゜1を用い、参考
例1.と同様に反応、処理し1゜1−ビー2−エトキシ
ナフタレンのラセミ体Q、86fを無色油状物として得
た。このものはすぐに固化した。収率50 %0物性値
は以下の通りであった。
Reference example 2 Reference example 1. 1.72°1 of 2-ethoxynaphthalene was used instead of 1.58f of 2-methoxynaphthalene in Reference Example 1. The mixture was reacted and treated in the same manner as above to obtain racemic Q, 86f of 1.1-bi-2-ethoxynaphthalene as a colorless oil. This stuff solidified quickly. The yield was 50%.The physical properties were as follows.

mp  1G&5〜107.5C(7セトン)NMR(
CD01B )δi、01(t、 6H)、 198(
q、 4H)。
mp 1G & 5~107.5C (7 setons) NMR (
CD01B) δi, 01(t, 6H), 198(
q, 4H).

70〜a1 (m、 12H) Me  (Ve)342(M”、 100)、 286
(26)、 26B(15)なお、物性値は市販の1,
1−ビー2−ナフトールをジメチルホルムアミド中、ヨ
ウ化エチルおよび水素化ナトリウムでエチル化して得た
標品のそれらと一致した。このエチル化で得た光学活性
体の標品の融点は137〜140C(ヘキサン)であっ
た。
70~a1 (m, 12H) Me (Ve) 342 (M”, 100), 286
(26), 26B (15) The physical properties of commercially available 1,
They were consistent with those of the standard obtained by ethylating 1-bi-2-naphthol with ethyl iodide and sodium hydride in dimethylformamide. The melting point of the standard optically active substance obtained by this ethylation was 137 to 140C (hexane).

実施倒毛 参考例2で得られ・た1、1′−ビー2−エトキシナフ
タレンのラセミ体770ダをアセトン1α2tに溶解さ
せた後20Cに冷却し、粉末化した□体3五5#((a
)”、’ +67.0’(c=to、 0HOts)。
The racemic form of 1,1'-bi-2-ethoxynaphthalene obtained in Reference Example 2 (770 da) was dissolved in acetone 1α2t, cooled to 20 C, and powdered □ body 355# (( a
)”, '+67.0' (c=to, 0HOts).

100%e、e、 )を接種した。19Cに冷却し1時
間攪拌した後濾過した。結晶部分は127.3Wで〔α
式+2y、s°(41,0%e、e、)、 fp液部分
を濃縮すると692■で〔αパー1.8°(2−7%e
、e、 )だった。4体、1体が1911Ig増大した
ことになる。
100% e, e, ) were inoculated. The mixture was cooled to 19C, stirred for 1 hour, and then filtered. The crystal part is 127.3W [α
Formula +2y, s° (41,0% e, e,), concentrating the fp liquid part gives 692■ [α par 1.8° (2-7% e,
, e, ). This means that 1 out of 4 patients had an increase in 1911Ig.

Claims (2)

【特許請求の範囲】[Claims] (1)式( I ) ▲数式、化学式、表等があります▼( I ) (式中、R^1およびR^2はアルキル基を示す。)で
表わされる1,1′−ビ−2−ナフトール誘導体のラセ
ミ体、あるいは一方の光学活性体が他方の光学活性体よ
り過剰に存在する混合体を溶媒に溶解させた後、冷却し
過飽和とした後、いずれか一方の光学活性体を接種し、
晶析分割することを特徴とする光学活性な1,1′−ビ
−2−ナフトール誘導体の光学分割法。
(1) Formula (I) ▲There are mathematical formulas, chemical formulas, tables, etc.▼(I) 1,1'-bi-2- represented by (In the formula, R^1 and R^2 represent an alkyl group) A racemic naphthol derivative or a mixture in which one optically active form is present in excess of the other is dissolved in a solvent, cooled to supersaturation, and then either one of the optically active forms is inoculated. ,
A method for optical resolution of optically active 1,1'-bi-2-naphthol derivatives, characterized by crystallization resolution.
(2)式( I )の式中のR^1とR^2が同一で、低
級アルキル基である特許請求の範囲第(1)項記載の光
学分割法。
(2) The optical resolution method according to claim (1), wherein R^1 and R^2 in formula (I) are the same and are lower alkyl groups.
JP13265285A 1985-06-18 1985-06-18 Optical resolution of 1,1'-bi-2-naphthol derivative Granted JPS61291535A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13265285A JPS61291535A (en) 1985-06-18 1985-06-18 Optical resolution of 1,1'-bi-2-naphthol derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13265285A JPS61291535A (en) 1985-06-18 1985-06-18 Optical resolution of 1,1'-bi-2-naphthol derivative

Publications (2)

Publication Number Publication Date
JPS61291535A true JPS61291535A (en) 1986-12-22
JPH0580461B2 JPH0580461B2 (en) 1993-11-09

Family

ID=15086325

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13265285A Granted JPS61291535A (en) 1985-06-18 1985-06-18 Optical resolution of 1,1'-bi-2-naphthol derivative

Country Status (1)

Country Link
JP (1) JPS61291535A (en)

Also Published As

Publication number Publication date
JPH0580461B2 (en) 1993-11-09

Similar Documents

Publication Publication Date Title
JPH09505035A (en) Novel pyrazine carboxamide derivatives, their preparation and use in pharmaceutical compositions
JPH05503534A (en) Method for producing (2R,3R)-cis-β-phenylglycidic acid
CA2451979C (en) Novel modifications of the trometamol salt of r-thioctic acid and method for producing the same
FR2655651A1 (en) POSSIBLY THERMOTROPIC POLYMOLECULAR ASSOCIATIONS OF WHICH THE BASIC MONOMERS ARE BOUND BETWEEN THEM BY HYDROGEN BONDS, A PROCESS FOR PREPARING THE SAME, AND BASIC MONOMERS FOR THE IMPLEMENTATION OF SAID METHOD.
JPS61291535A (en) Optical resolution of 1,1&#39;-bi-2-naphthol derivative
WO2023059610A1 (en) Crystalline forms and processes for the preparation of cannabinoid receptor modulators
US4772628A (en) Organogermanium compound and antitumor agent composed mainly of this compound
JPH05194491A (en) Imidazolylmethylpyridine
Szczesna et al. Solid-to-solid reaction of 2, 4-dinitrophenylhydrazine with several aromatic aldehydes bearing electron-donating groups
JP2002530392A (en) Crystal of 5-[{6- (2-fluorobenzyl) oxy-2-naphthyl} methyl] -2,4-thiazolidinedione
JP3851992B2 (en) Method for producing asymmetric azines
Kozerski et al. Regioselective reactions of enaminones with enones—II: Intramolecular rearrangement involving carbon to oxygen acyl migrations
Lange et al. Bromination of 2, 2, 6-trialkyl-1, 3-dioxan-4-ones. Application of the deuterium isotope effect to the synthesis of a chiral trialkyldioxinone
EP0716091A1 (en) Tris(substituted phenyl)bismuth derivative
JP3432880B2 (en) Preparation of optically active azaspiro compounds
JPS62249963A (en) Manufacture of n-(sulfonylmethyl)formaldehydes
JPS6032783A (en) Fluorine-containing coumarins
Křepelka et al. Some derivatives of 4-aryl-2, 3-dicyano-1-naphthol
KR820001271B1 (en) Process for preparaing 2-deoxy-5-fluoro-uridine derivatives
US5041620A (en) Method for producing optically active 2-cyclopenten-4-one-1-ol esters, 2-cyclopenteno-4-one-1-ol ester and complexes thereof with optically active 1,6-diphenyl-2,4-hexadiyne-1,6-diol
CA1148552A (en) Preparation of germaazaspirodiones and germaazaspiranes
JPS5865249A (en) Manufacture of dichloroacetic acid ester
EP0048107A2 (en) Crystalline prostaglandins
JPH0798802B2 (en) Process for producing optically active indoline-2-carboxylic acid
JPH04139170A (en) Substituted pyridinesufonylcarbamate-based compound, its production and production of substituted pyridinesulfonamide-based compound